使用SAPIEN 3装置的标准微创经股动脉经导管主动脉瓣置换术：步骤描述、可行性和安全性（大样本单中心单操作者队列）

数据集获取（Figshare）

• 源站标题：Standardized Minimalistic Transfemoral Transcatheter Aortic Valve Replacement (TAVR) Using the SAPIEN 3 Device: Stepwise Description, Feasibility, and Safety from a Large Consecutive Single-Center Single-Operator Cohort
• DOI：10.6084/m9.figshare.5264134.v2
• 发布日期：2017-08-08
• 文件数：4 个
• 文件总体积：49.38 MB
• 源站页面：https://tandf.figshare.com/articles/dataset/Standardized_minimalistic_transfemoral_transcatheter_aortic_valve_replacement_TAVR_using_the_SAPIEN_3_device_Stepwise_description_feasibility_and_safety_from_a_large_consecutive_single-center_single-operator_cohort/5264134

命令行下载

curl -L -o "R1_supplementary figure 1.tif" "https://ndownloader.figshare.com/files/9004189"
curl -L -o "R1_supplementary figure 2.tif" "https://ndownloader.figshare.com/files/9004192"
curl -L -o "Supplementary material_16022017.docx" "https://ndownloader.figshare.com/files/9004195"
curl -L -o "supplementary_movie.mov" "https://ndownloader.figshare.com/files/9004198"

文件清单

• R1_supplementary figure 1.tif（12.56 MB）
• R1_supplementary figure 2.tif（12.55 MB）
• Supplementary material_16022017.docx（34.98 KB）
• supplementary_movie.mov（24.24 MB）

文件总体积 49.38 MB（源站 API 实测）。

数据说明

Background: To describe our updated minimalist approach (MA) for transfemoral transcatheter aortic valve replacement (TF-TAVR) using the SAPIEN 3 device and its evolution, as well as associated safety and efficacy parameters from a large cohort of patients.
Methods: A stepwise description of the MA technique for TAVR for 300 consecutive patients was detailed. Safety and efficacy parameters were assessed using the VARC-2 criteria at the in-hospital and 30-days follow-up.
Results: A total of 300 consecutive patients (80 ± 7 years; median Logistic EuroSCORE of 11.4% [7.5–17.8]) between January 2014 and May 2016 were evaluated. TF-TAVR was performed under conscious sedation in 247 (82%) patients. Device success was achieved in 286 (95.6%) patients, and intended prosthesis performance in 289 (96.3%) patients. Significant paravalvular leak (PVL) graded more than mild was noted in 7 (2%) patients. No patient had severe PVL. All-cause mortality was noted in one (0.3%) patient in-hospital and in 2 (0.7%) patients at the 30-days follow-up. Major stroke occurred in 4 (1.3%) patients. 9 (3%) patients had major vascular complications at 30-days follow up. MACCE (VARC-2 criteria) were observed in 21 (7%) in-hospital and 25 (8.3%) at 30 days. A new permanent pacemaker implantation was required in 29 (10.7%) patients, and was reduced from 18% to 5.6% (p = 0.001) in a subgroup analysis considering higher implantation position of the valve after the first year of experience.
Conclusion: MA of TF-TAVR, when simplified and standardized, is reproducible, safe and efficient, and should be encouraged to be accepted as the standard method of care.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.5264134.v2（source: https://tandf.figshare.com/articles/dataset/Standardized_minimalistic_transfemoral_transcatheter_aortic_valve_replacement_TAVR_using_the_SAPIEN_3_device_Stepwise_description_feasibility_and_safety_from_a_large_consecutive_single-center_single-operator_cohort/5264134）。